These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22589395)

  • 1. Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.
    Zorniak M; Clark PA; Leeper HE; Tipping MD; Francis DM; Kozak KR; Salamat MS; Kuo JS
    Clin Cancer Res; 2012 Jul; 18(13):3628-36. PubMed ID: 22589395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.
    Zorniak M; Clark PA; Kuo JS
    J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quest for self-identity: not all cancer stem cells are the same.
    Hjelmeland AB; Rich JN
    Clin Cancer Res; 2012 Jul; 18(13):3495-8. PubMed ID: 22711710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.
    Tasaki T; Fujita M; Okuda T; Yoneshige A; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A
    Anticancer Res; 2016 Jul; 36(7):3571-7. PubMed ID: 27354625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.
    Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V
    Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic mapping of glioblastoma stem cells reveals NADH fluxes associated with glioblastoma phenotype and survival.
    Schroeder A; Pointer K; Clark P; Datta R; Kuo J; Eliceiri K
    J Biomed Opt; 2020 Mar; 25(3):1-13. PubMed ID: 32216192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.
    Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM
    J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
    NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
    Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V
    Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
    Ricci-Vitiani L; Pallini R; Biffoni M; Todaro M; Invernici G; Cenci T; Maira G; Parati EA; Stassi G; Larocca LM; De Maria R
    Nature; 2010 Dec; 468(7325):824-8. PubMed ID: 21102434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of collagen architecture with glioblastoma patient survival.
    Pointer KB; Clark PA; Schroeder AB; Salamat MS; Eliceiri KW; Kuo JS
    J Neurosurg; 2017 Jun; 126(6):1812-1821. PubMed ID: 27588592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSNK1D is associated with stemness and invasiveness in glioblastoma.
    Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
    Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.